Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read moreTweets from GSK
-
GSK @GSK
#News for #investors and #media — Today at @IAS_conference ViiV, our specialist HIV company, shared data from our SALSA study. Further information at gsk.com #IAS2021
about 13 hours ago
-
GSK @GSK
#WeWontStop until the right HIV care and support is available to all. Today is the first day of #IAS2021 and @ViiVHC, our specialist HIV company are excited to be a part of the conversation. Learn more: gsk.to/3zcDiKe @IAS_conference
about 1 day ago
-
GSK @GSK
#News for #investors and #media — At @IAS_conference, the implementation science team at ViiV, our specialist HIV company, are sharing results from the CUSTOMIZE study. Further information at gsk.com #IAS2021
about 2 days ago